Literature DB >> 31992106

Factors affecting recurrence and management of recurrent cerebral aneurysms after initial coiling.

Yongfeng Han1,2, Jian Liu1, Zhongbin Tian1, Ming Lv1, Xinjian Yang1, Zhongxue Wu1, Bu-Lang Gao2.   

Abstract

OBJECTIVE: To investigate factors affecting recurrence and effects and safety of endovascular retreatment for aneurysms recurrent after embolization.
METHODS: Among 815 aneurysms treated with embolization, recurrence was in 114 aneurysms (14.0%). Forty-three recurrent aneurysms were managed with re-embolization. Procedural complications, angiographic, and clinical results of retreatment were analyzed.
RESULTS: Patients with recurrent aneurysms were significantly (P < 0.01) younger than without recurrence (51.09 ± 10.46 vs. 53.88 ± 9.61 years). Recurrent aneurysms (n = 114) were significantly (P = 0.00) greater (11.12 ± 8.35 vs. 5.81 ± 3.44 mm) with a significantly (P = 0.00) greater neck (4.34 ± 2.26 vs. 2.90 ± 1.44 mm) than without recurrence. The rupture status of aneurysms significantly (P = 0.00) affected recurrence at follow-up. Significantly (P = 0.00) more aneurysms without recurrence were treated with advanced embolization techniques (81.0% vs. 62.3%) and got complete occlusion at the first embolization than those with recurrence (93.7% vs. 36.8%). In treating 43 recurrent aneurysms, stent-assisted recoiling was used in 48.8% in the first retreatment and 50% in the second and third retreatment procedures. Angiographic follow-up in 38 (88.4%) cases showed complete or near complete occlusion in 30 aneurysms, with the rest eight aneurysms experiencing a second recurrence (21.1%). Of the eight aneurysms with the second recurrence, five underwent the second endovascular retreatment, with complete aneurysm occlusion achieved in three cases (60%), near-complete occlusion in one (20%), and incomplete occlusion in one case at immediate angiography and six-month follow-up. Procedure-related complications occurred in three patients.
CONCLUSIONS: Endovascular retreatment of recurrent previously coiled aneurysms is safe and effective even though advanced embolization techniques are frequently involved especially for large and giant aneurysms.

Entities:  

Keywords:  Cerebral aneurysm; embolization; endovascular retreatment; pipeline embolization device; recurrence

Mesh:

Year:  2020        PMID: 31992106      PMCID: PMC7254619          DOI: 10.1177/1591019919901037

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  35 in total

1.  Procedural morbidity and mortality of elective coil treatment of unruptured intracranial aneurysms.

Authors:  W J van Rooij; M Sluzewski
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

2.  Rates of delayed rebleeding from intracranial aneurysms are low after surgical and endovascular treatment.

Authors: 
Journal:  Stroke       Date:  2006-04-20       Impact factor: 7.914

3.  International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.

Authors:  Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

4.  Does stent implantation improve the result of repeat embolization in recanalized aneurysms?

Authors:  Young Dae Cho; Jong Young Lee; Jung Hwa Seo; Seung Jin Lee; Hyun-Seung Kang; Jeong Eun Kim; Young Je Son; Keun-Hwa Jung; O-Ki Kwon; Moon Hee Han
Journal:  Neurosurgery       Date:  2012-12       Impact factor: 4.654

5.  Pipeline for uncoilable or failed aneurysms: results from a multicenter clinical trial.

Authors:  Tibor Becske; David F Kallmes; Isil Saatci; Cameron G McDougall; István Szikora; Giuseppe Lanzino; Christopher J Moran; Henry H Woo; Demetrius K Lopes; Aaron L Berez; Daniel J Cher; Adnan H Siddiqui; Elad I Levy; Felipe C Albuquerque; David J Fiorella; Zsolt Berentei; Miklós Marosfoi; Saruhan H Cekirge; Peter K Nelson
Journal:  Radiology       Date:  2013-02-15       Impact factor: 11.105

6.  Repeat endovascular treatment in post-embolization recurrent intracranial aneurysms.

Authors:  Hyun-Seung Kang; Moon Hee Han; Bae Ju Kwon; O-Ki Kwon; Sung Hyun Kim
Journal:  Neurosurgery       Date:  2006-01       Impact factor: 4.654

Review 7.  An approach to recurrent aneurysms following endovascular coiling.

Authors:  Jean Raymond; Tim E Darsaut
Journal:  J Neurointerv Surg       Date:  2011-02-25       Impact factor: 5.836

8.  Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils.

Authors:  Jean Raymond; François Guilbert; Alain Weill; Stavros A Georganos; Louis Juravsky; Anick Lambert; Julie Lamoureux; Miguel Chagnon; Daniel Roy
Journal:  Stroke       Date:  2003-05-29       Impact factor: 7.914

9.  Long-term follow-up of cerebral aneurysms after endovascular therapy prediction and outcome of retreatment.

Authors:  T Ries; S Siemonsen; G Thomalla; U Grzyska; H Zeumer; J Fiehler
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

10.  Retreatment of previously embolized cerebral aneurysms: the risk of further coil embolization does not negate the advantage of the initial embolization.

Authors:  S A Renowden; P Koumellis; V Benes; W Mukonoweshuro; A J Molyneux; N S McConachie
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-24       Impact factor: 3.825

View more
  2 in total

1.  A case of recurrent aneurysm resulting from dual antiplatelet plus anticoagulation after confirmed aneurysm closure following coil-assisted flow diversion.

Authors:  Thomas R Geisbush; Benjamin Pulli; Dylan N Wolman; Arjun V Pendharkar; Nicholas A Telischak
Journal:  Radiol Case Rep       Date:  2022-08-27

2.  Risk factors for repeated recurrence of cerebral aneurysms treated with endovascular embolization.

Authors:  Yong-Feng Han; Peng Jiang; Zhong-Bin Tian; Xi-Heng Chen; Jian Liu; Zhong-Xue Wu; Bu-Lang Gao; Chun-Feng Ren
Journal:  Front Neurol       Date:  2022-09-29       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.